Literature DB >> 11494874

In vitro human immunodeficiency virus type 1 integrase assays.

C Marchand1, N Neamati, Y Pommier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11494874     DOI： 10.1016/s0076-6879(01)40446-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  19 in total

1.  Probing chelation motifs in HIV integrase inhibitors.

Authors:  Arpita Agrawal; Jamie DeSoto; Jessica L Fullagar; Kasthuraiah Maddali; Shahrzad Rostami; Douglas D Richman; Yves Pommier; Seth M Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-27       Impact factor: 11.205

Review 2.  Authentic HIV-1 integrase inhibitors.

Authors:  Chenzhong Liao; Christophe Marchand; Terrence R Burke; Yves Pommier; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

3.  Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir.

Authors:  Mathieu Métifiot; Kasthuraiah Maddali; Alena Naumova; Xuemin Zhang; Christophe Marchand; Yves Pommier
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

4.  Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.

Authors:  S Kehlenbeck; U Betz; A Birkmann; B Fast; A H Göller; K Henninger; T Lowinger; D Marrero; A Paessens; D Paulsen; V Pevzner; R Schohe-Loop; H Tsujishita; R Welker; J Kreuter; H Rübsamen-Waigmann; F Dittmer
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Acetylation of HIV-1 integrase by p300 regulates viral integration.

Authors:  Anna Cereseto; Lara Manganaro; Maria Ines Gutierrez; Mariaelena Terreni; Antonio Fittipaldi; Marina Lusic; Alessandro Marcello; Mauro Giacca
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

6.  Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.

Authors:  Rajeshri G Karki; Yun Tang; Terrence R Burke; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

7.  Synthesis, Antiinflammatory and HIV-1 Integrase Inhibitory Activities of 1,2-Bis[5-thiazolyl]ethane-1,2-dione Derivatives.

Authors:  P X Franklin; S Yerande; H M Thakar; G S Inamdar; R S Giri; H Padh; V Sudarsanam; Kamala K Vasu
Journal:  Indian J Pharm Sci       Date:  2009-05       Impact factor: 0.975

8.  Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate.

Authors:  Krishan K Pandey; Sibes Bera; Jacob Zahm; Ajaykumar Vora; Kara Stillmock; Daria Hazuda; Duane P Grandgenett
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

9.  Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants.

Authors:  Jessica Marinello; Christophe Marchand; Bryan T Mott; Anjali Bain; Craig J Thomas; Yves Pommier
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

10.  Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products.

Authors:  Wataru Nomura; Haruo Aikawa; Nami Ohashi; Emiko Urano; Mathieu Métifiot; Masayuki Fujino; Kasthuraiah Maddali; Taro Ozaki; Ami Nozue; Tetsuo Narumi; Chie Hashimoto; Tomohiro Tanaka; Yves Pommier; Naoki Yamamoto; Jun A Komano; Tsutomu Murakami; Hirokazu Tamamura
Journal:  ACS Chem Biol       Date:  2013-08-15       Impact factor: 5.100
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.